SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Maulcoin

Maulcoin is capturing significant attention as the community rallies around its organic growth and aggressive 'Sith-themed' branding, with supporters actively pushing for higher market capitalization milestones and celebrating the avoidance of a rug-pull structure. Traders are focused on the stock's strong community-driven momentum and volume spikes, viewing current price action as a consolidation period before the next major leg up.

Assertio Holdings, Inc. is a commercial pharmaceutical company, which engages in acquisitions, licensing, and mergers. The firm focuses on portfolio of neurology, inflammation, and pain medications. Its products include INDOCIN, Sympazan, Otrexup, SPRIX, CAMBIA, and Zipsor. The company was founded on August 7, 1995 and is headquartered in Lake Forest, IL.

Assertio Holdings Inc

Assertio Holdings is facing intense shareholder scrutiny and frustration following a surprise acquisition agreement with Garda Therapeutics, with investors questioning the deal's valuation and potential conflicts of interest. The community is actively discussing the possibility of blocking the tender offer, coordinating with major shareholders, and investigating the timeline of the board's decision-making process.

Ethereum is a global, open-source platform for decentralized applications. In other words, it is a decentralized blockchain platform that enables developers to build and deploy smart contracts and applications without central authority control. Unlike Bitcoin, which primarily functions as digital currency, Ethereum operates as a programmable global computer where developers can create any type of decentralized service.   The platform hosts over $14 billion in DeFi applications with hundreds of thousands of active users across financial protocols, NFT marketplaces, and gaming platforms. Its transition to Proof of Stake in September 2022 reduced energy consumption by over 99%, addressing environmental concerns while strengthening network security.  The network operates through thousands of independent validator nodes that process transactions and execute smart contracts on the Ethereum Virtual Machine. Smart contracts are self-executing programs written in Solidity that automatically carry out agreements when conditions are met, eliminating intermediaries like banks or brokers.   Validators stake ETH as collateral to propose and validate blocks, earning rewards for honest participation while facing penalties for malicious behavior. The EIP-1559 upgrade introduced a dynamic base fee mechanism that burns ETH with each transaction, creating deflationary pressure during high network activity when more ETH is burned than issued to validators.  Vitalik Buterin proposed Ethereum in 2013, but seven co-founders helped build it, including Gavin Wood who created Solidity and the EVM technical specification, and Joseph Lubin who founded ConsenSys. The project launched in July 2015 after raising over $18 million through crowdfunding, quickly becoming the largest blockchain developer community. Major milestones include the 2020 Beacon Chain launch, the 2021 London hard fork implementing fee burning, and the 2022 Merge to Proof of Stake.   Ether (ETH) serves multiple functions: paying transaction fees (gas), staking to secure the network and earn 3-5% annual yields, serving as collateral in DeFi protocols, and purchasing NFTs and digital assets. The asset is increasingly adopted by traditional institutions, with publicly traded companies adding ETH to corporate treasuries to generate staking yields while maintaining blockchain exposure, and in 2024, the SEC approved spot Ethereum ETFs, allowing traditional investors to gain exposure through conventional brokerage accounts.  Ethereum's roadmap focuses on dramatically increasing transaction capacity to over 100,000 per second, reducing confirmation times, and enhancing decentralization while maintaining security against future threats like quantum computing.

Ethereum

Ethereum is facing a tug-of-war between institutional optimism and lingering geopolitical anxiety, as traders monitor massive ETF inflows against potential supply-chain disruptions in the Strait of Hormuz. The community remains deeply divided, with bulls pointing to technical breakouts and supply squeezes while bears warn that unresolved regional conflicts could trigger renewed volatility.

What Is Tezos (XTZ)?   Tezos is a high-performing blockchain and open-source platform for assets and applications, with a strong focus on code security, on-chain governance, and decentralization. Tezos 2.0, the upcoming step in the evolution of Tezos, aims to improve scalability (via layer 2s), composability, and to implement support to mainstream programming languages (like Javascript, Typescript, Python, and many others).   Initially built with formal verification in mind, the Tezos protocol enables builders to avoid bugs when developing smart contracts, making it particularly suited to applications that require a high degree of security and certainty.   Tezos’ LPoS (Liquid Proof-of-Stake) consensus mechanism enables any stakeholder to take part, directly or by delegation, in the consensus process, and to be rewarded for securing the network. Rather uniquely, Tezos’ on-chain governance system also enables stakeholders to create and vote on protocol upgrade proposals. This pioneering system allows the protocol to self-amend and upgrade itself without leading to a split (or fork) in the blockchain, empowering the community without slowing down innovation.   First proposed in 2014 and launched in 2018, the Tezos Mainnet has a proven track record of running uninterrupted ever since, having earned a strong reputation for technical excellence and a supportive community.    Who Are the Founders of Tezos? Tezos was conceived by Arthur and Kathleen Breitman in a 2014 white paper under the pseudonym L.M. Goodman in a nod to Satoshi Nakamoto, referencing a journalist who had misidentified the creator of Bitcoin.   In a previous paper, the Breitmans had argued that Bitcoin's biggest shortcomings were the lack of a governance process that invited contributions from its community of users, cost and centralization issues raised by its proof-of-work system, the limited expressiveness of its programming language which didn’t allow for smart contracts, and security

Tezos

Tezos (XTZ) is facing intense social media debate, with investors divided between those viewing recent price volatility as a setup for a potential recovery and vocal detractors warning of an "epic dump." The community is heavily focused on technical resistance levels and macroeconomic catalysts, such as the potential impact of the Clarity Act and broader altcoin market trends.

Bitcoin is the world's first decentralized cryptocurrency, created in 2009 by the pseudonymous Satoshi Nakamoto. It enables peer-to-peer electronic cash transactions without intermediaries like banks or governments, operating on a blockchain secured by Proof of Work mining and the SHA-256 cryptographic algorithm.   With a fixed supply cap of 21 million coins and programmatic halvings every four years that reduce miner rewards, Bitcoin is designed as a deflationary digital asset often called "digital gold." Its value stems from solving the double-spending problem without trusted intermediaries, creating the first truly scarce digital asset with censorship resistance and permissionless access that no government, corporation, or individual can control.  Bitcoin operates as a decentralized peer-to-peer network where transactions are recorded on a public ledger called the blockchain, distributed across thousands of computers globally. Transactions are grouped into blocks added approximately every 10 minutes through mining, where specialized computers compete to solve complex mathematical puzzles.   Bitcoin has achieved mainstream adoption through multiple vectors. The January 2024 SEC approval of 11 spot Bitcoin ETFs opened Bitcoin investment to traditional finance participants, and corporations like Strategy (formerly MicroStrategy) are using Bitcoin as a treasury reserve asset to protect against currency debasement, offering MSTR holders amplified exposure to Bitcoin.   The Bitcoin ecosystem continues to evolve with innovations like Ordinals, which emerged in January 2023 to enable NFT-like functionality directly on Bitcoin, and BRC-20 tokens, an experimental standard for creating fungible tokens using Ordinal inscriptions. BTCFi (Bitcoin Finance) represents emerging financial applications extending beyond Bitcoin's traditional role, with protocols like Babylon allowing Bitcoin holders to stake BTC to secure Proof of Stake chains.

Bitcoin

Bitcoin is currently experiencing intense market volatility and price sensitivity as investors react to the stalled U.S.-Iran negotiations regarding the Strait of Hormuz. While some community members view the current price action as a bear trap amidst institutional accumulation, others are bracing for deeper pullbacks, with sentiment heavily influenced by the interplay between ongoing geopolitical tensions and broader macroeconomic signals.

Hyperliquid is a layer one (L1) blockchain best known for perpetual futures and spot trading. Beyond its flagship DEX trading platform, the ecosystem supports borrowing, lending, real world assets (RWAs), and a full-fledged Ethereum Virtual Machine (EVM), making it a leading force in decentralized finance (defi).   Just as electronic trading dramatically improved markets in the 2000s, Hyperliquid offers an opportunity for a massive technical upgrade of the existing financial system through a transparent, efficient, and resilient blockchain. HYPE is the native token of the Hyperliquid blockchain, with a maximum supply of 1 billion.

Hype

HYPE is currently trending as a centerpiece of the decentralized perpetual exchange market, with community discussion centered on its high-volume ecosystem and potential for future institutional adoption. Traders are actively tracking its momentum against other crypto assets and discussing strategic entry points, driven by recent exchange listings and the ongoing narrative of HYPE serving as a 'house of all finance' within the DeFi space.

Halliburton Co. engages in the provision of products and services to the energy industry. It operates through the Completion and Production, and Drilling and Evaluation segments. The Completion and Production segment focuses on cementing, stimulation, specialty chemicals, intervention, pressure control, artificial lift, and completion products and services. The Drilling and Evaluation segment provides field and reservoir modeling, drilling, fluids, evaluation, and wellbore placement solutions that enable customers to model, measure, drill, and optimize well construction activities. The company was founded by Erle P. Halliburton in 1919 and is headquartered in Houston, TX.

Halliburton Co.

Halliburton is seeing heightened market attention driven by expectations of a revival in U.S. investment in Venezuelan energy infrastructure and broader geopolitical tensions that have bolstered the energy sector. Investors are actively discussing the stock's potential for a long-term uptrend while weighing operational risks, with bullish sentiment supported by aggressive call option activity and institutional interest in energy infrastructure resilience.

Energous Corp. engages in the development of wireless charging technology. It focuses on the product, WattUp, a wireless power technology consisting of proprietary semiconductor chipsets, software controls, hardware designs, and antennas, that enables radio frequency based charging for electronic devices. The company was founded by Michael Aaron Leabman in 2012 and is headquartered in San Jose, CA.

Energous Corp

Energous Corp is gaining momentum as investors track its shift from R&D to commercial deployment, highlighted by record annual revenue growth and the strategic expansion of its PowerBridge wireless power infrastructure within major retail environments. The community is actively debating the company's long-term potential, focusing on institutional accumulation, low float volatility, and the impact of recent regulatory approvals as traders weigh the significance of pending earnings reports.

Aurinia Pharmaceuticals, Inc. is a clinical stage bio-pharmaceutical company, which engages in the research, development, and commercialization of therapeutic drugs. The company was founded by Robert Foster, Richard Glickman, and Michael Martin on June 16, 1993 and is headquartered in Edmonton, Canada.

Aurinia Pharmaceuticals Inc

Aurinia Pharmaceuticals is trending following a significant leadership overhaul that replaced CEO Peter Greenleaf with Chairman Kevin Tang, a move widely interpreted by the community as a strategic signal that the company is being positioned for a potential buyout. Investors are actively debating the implications of this transition, including the acquisition of Kezar Life Sciences and the potential for Tang to leverage the companys remaining assets, such as Lupkynis and the Aritinercept pipeline, to maximize shareholder value.

Bloom Energy Corp. engages in the manufacture and installation of a solid oxide fuel-cell based power generation platform. Its product, Bloom Energy Server, converts standard low-pressure natural gas or biogas into electricity through an electrochemical process without combustion. The company was founded by K. R. Sridhar, John Finn, Jim McElroy, Matthias Gottmann, and Dien Nguyen on January 18, 2001, and is headquartered in San Jose, CA.

Bloom Energy Corp - Ordinary Shares - Class A

Bloom Energy Corp

Bloom Energy is currently a focal point for investors as high-volume volatility and technical patterns spark intense debate over whether the stock is undergoing a healthy consolidation or a deeper correction following recent expansion news. The community remains sharply divided, with many traders viewing the current price action as a strategic buying opportunity driven by the company's critical role in the secular AI power infrastructure theme, while others caution against potential overvaluation and macroeconomic headwinds.

statis crypto Watchlist

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$DARE Disclaimer:
This material is provided for informational purposes only and does not constitute financial, investment, or legal advice.
All financial figures, assumptions, and projections presented herein are preliminary estimates based on publicly available information and high-level assumptions and should be considered an amateur assessment.

Ovaprene – Daré Bioscience

Product Overview
 • Non-hormonal monthly intravaginal contraceptive in Phase 3
 • First hormone-free monthly prescription contraceptive in the U.S. if FDA-approved
 • Targets growing demand for non-hormonal alternatives

Strategic Update
 • Bayer Exit: U.S. commercialization rights returned 2025
 • Rights Reversion: Full U.S. rights to Daré (Feb 2026) → full strategic flexibility

Bernd Roessle

$DARE Then add their other assets in the pipeline and also revenues from Dare to Play - rNPV could be many times higher than what can be estimated for Ovaprene. No advice.

StockTwits for iOS

BuyAndHold

$DARE In “Modern non-hormonal contraceptive methods: development prospects and current state of knowledge” (Medical Science, 2026), Biernacki et al. review the current landscape and future direction of non-hormonal contraception.

https://www.researchgate.net/publication/401448234_Modern_non-hormonal_contraceptive_methods_development_prospects_and_current_state_of_knowledge

The authors highlight the ongoing need for effective contraceptive options that avoid hormonal side effects. At present, the copper IUD remains the most established and reliable non-hormonal method and is considered safe for most users, including nulliparous women.

Dare Bioscience Inc

 Disclaimer:
This material is provided for informational purposes only and does not constitute financial, investment, or legal advice.
All financial figures, assumptions, and projections presented herein are preliminary estimates based on publicly available information and high-level assumptions and should be considered an amateur assessment.

Ovaprene – Daré Bioscience

Product Overview
 • Non-hormonal monthly intravaginal contraceptive in Phase 3
 • First hormone-free monthly prescription contraceptive in the U.S. if FDA-approved
 • Targets growing demand for non-hormonal alternatives

Strategic Update
 • Bayer Exit: U.S. commercialization rights returned 2025
 • Rights Reversion: Full U.S. rights to Daré (Feb 2026) → full strategic flexibility

Whirlpool Corp.

Weyerhaeuser Co

SPDR S&P Biotech ETF

Sarepta Therapeutics Inc

Potential Partners

Most likely: Organon | Strong alternative: CooperCompanies

Licensing &amp; Commercialization Economics

Component
Upfront $5M Immediate licensing payment

Milestones $81M Regulatory &amp; sales milestones

Long-term royalties (PV, 15% discount) $205M Risk-adjusted 54% approval probability

Total rNPV $291M  Combines near- &amp; long-term value

Per-share value (14 M shares): $20.79/share

Sensitivity:
 • Conservative: $125 M → $8.93/share
 • Base: $291 M → $20.79/share
 • Bull: $505 M → $36.07/share

Compared to the agreement with Bayer, milestone assumptions are lower. Upfront higher, as the study is soon to be completed.

Licensing & Commercialization Economics

Component
Upfront $5M Immediate licensing payment

Milestones $81M Regulatory & sales milestones

Long-term royalties (PV, 15% discount) $205M Risk-adjusted 54% approval probability

Total rNPV $291M  Combines near- & long-term value

Per-share value (14 M shares): $20.79/share

Sensitivity:
 • Conservative: $125 M → $8.93/share
 • Base: $291 M → $20.79/share
 • Bull: $505 M → $36.07/share

Compared to the agreement with Bayer, milestone assumptions are lower. Upfront higher, as the study is soon to be completed.

Market &amp; Commercial Potential
 • Peak U.S. Estimate net sales: $350 M
 • Royalty rate: 15%
 • 10-year commercial window
 • Differentiated: hormone-free, user-controlled, monthly

Peak U.S. Estimate net sales are modestly assumed compared to NuvaRing. Among already established products in the US, NuvaRing is clearly the most comparable in terms of form and usage frequency, with a historically high sales volume (approximately USD 900 million per year). 

https://www.nasdaq.com/press-release/teva-announces-launch-of-a-generic-version-of-nuvaringr-etonogestrel-and-ethinyl?utm_source=chatgpt.com

TEL AVIV, Israel& PARSIPPANY, N.J.---- Teva Pharmaceuticals USA, Inc., a U.S. affiliate of Teva Pharmaceutical Industries Ltd., today announced the availability of a generic version of NuvaRing ® 1, 0.120 mg/0. 015 mg per day, in the U.S. Teva' s AB-rated and bioequivalent etonogestrel and ethinyl estradiol vaginal ring, is an estrogen/progestin combination hormonal...

Nasdaq

Teva Announces Launch of a Generic Version of NuvaRing® (etonogestrel and ethinyl estradiol) Vaginal Ring in the United States

Market & Commercial Potential
 • Peak U.S. Estimate net sales: $350 M
 • Royalty rate: 15%
 • 10-year commercial window
 • Differentiated: hormone-free, user-controlled, monthly

Peak U.S. Estimate net sales are modestly assumed compared to NuvaRing. Among already established products in the US, NuvaRing is clearly the most comparable in terms of form and usage frequency, with a historically high sales volume (approximately USD 900 million per year). 



Key Highlights
 1. First-in-category non-hormonal contraceptive
 2. Full U.S. rights returned → full strategic flexibility
 3. Strong partner prospects: Organon, CooperCompanies
 4. Attractive rNPV: $20.79/share base case
 5. Clear value through upfront + milestones + royalties

Disclaimer:
This material is provided for informational purposes only and does not constitute financial, investment, or legal advice.
All financial figures, assumptions, and projections presented herein are preliminary estimates based on publicly available information and high-level assumptions and should be considered an amateur assessment.